Document 4vrGGKyMXkRgk9QL0Z8VaZ09R

all documents referring to, relating to, and/or reflecting the same: (a) Asbestos; (b) Asbestos-related disease; (c) The hazards of asbestos; (d) Working with and/or around asbestos (including, but not limited to, recommended practices, controls, TLVs, standards etc.); (e) Medical monitoring of persons working with and/or around asbestos and/or otherwise exposed to asbestos; (f) Marketing products; asbestos and/or asbestos-containing (g) Asbestos related claims and/or litigation; (h) The publication and/or dissemination of information concerning asbestos, asbestos-related diseases and/or the hazards of asbestos (including withholding the same); (i) Warning, cautions and/or notices concerning . asbestos, asbestos- related diseases and/or the hazards of asbestos (including withholding the same); (j) Government proceedings and/or actions regulating asbestos (including proposals to do so); (k) Medical/scientific information and/or research concerning (l) asbestos, asbestos-related diseases, ^working with and/or around asbestos, and/or the hazards of asbestos; (m) Occupational health and safety / industrial hygiene (as they concern asbestos, asbestosrelated diseases, working with and/or around asbestos, and/or the hazards of asbestos). ANSWER: - Gleason objects to this Interrogatory as overly broad, burdensome, harassing, excessive in scope and time and incorrectly implying that its products were a health hazard. By way of further response, see documents provided. By way of further response, Gleason has been involved GLEASON-000043